{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T04:15:55Z","timestamp":1785644155916,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17824969"],"award-info":[{"award-number":["17824969"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17KT0051"],"award-info":[{"award-number":["17KT0051"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H04971"],"award-info":[{"award-number":["18H04971"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03407"],"award-info":[{"award-number":["20H03407"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbadis.2024.167626","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T19:16:27Z","timestamp":1734030987000},"page":"167626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CDK8 inhibitor KY-065 rescues skeletal abnormalities in achondroplasia model mice"],"prefix":"10.1016","volume":"1871","author":[{"given":"Koki","family":"Sadamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tokumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutada","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shirahase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Hinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.bbadis.2024.167626_bb0005","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2024.167626_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2148-14-10","article-title":"Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages","volume":"14","author":"Cao","year":"2014","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.bbadis.2024.167626_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2022.12.006","article-title":"CDK inhibitors from past to present: a new wave of cancer therapy","volume":"88","author":"Mughal","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41571-023-00840-4","article-title":"The CDK4\/6 inhibitor revolution \u2014 a game-changing era for breast cancer treatment","volume":"21","author":"Morrison","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167626_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/trns.1.1.12373","article-title":"CDK8: a positive regulator of transcription","volume":"1","author":"Galbraith","year":"2010","journal-title":"Transcription"},{"key":"10.1016\/j.bbadis.2024.167626_bb0030","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41388-021-01745-1","article-title":"CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway","volume":"40","author":"Fukasawa","year":"2021","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbadis.2024.167626_bb0035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.stemcr.2022.06.001","article-title":"The role of CDK8 in mesenchymal stem cells in controlling osteoclastogenesis and bone homeostasis","volume":"17","author":"Yamada","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167626_bb0040","unstructured":"J.M. Legare, Achondroplasia, in: M.P. Adam, J. Feldman, G.M. Mirzaa, R.A. Pagon, S.E. Wallace, A. Amemiya (Eds.), GeneReviews(\u00ae), University of Washington, Seattle (Copyright \u00a9 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved., Seattle (WA)), 1993."},{"issue":"9582","key":"10.1016\/j.bbadis.2024.167626_bb0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167626_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0972-6","article-title":"Achondroplasia: a comprehensive clinical review","volume":"14","author":"Pauli","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167626_bb0055","first-page":"454","article-title":"Mortality in achondroplasia","volume":"41","author":"Hecht","year":"1987","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167626_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13023-019-1247-6","article-title":"Obesity in achondroplasia patients: from evidence to medical monitoring","volume":"14","author":"Saint-Laurent","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167626_bb0065","first-page":"215","article-title":"The fibroblast growth factor signaling pathway, Wiley interdisciplinary reviews","volume":"4","author":"Ornitz","year":"2015","journal-title":"Dev. Biol."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167626_bb0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1101\/gad.277137.115","article-title":"Genetic insights into the mechanisms of Fgf signaling","volume":"30","author":"Brewer","year":"2016","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0080","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167626_bb0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2004.11.012","article-title":"Cell responses to FGFR3 signalling: growth, differentiation and apoptosis","volume":"304","author":"L\u2019H\u00f4te","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2024.167626_bb0100","first-page":"123","article-title":"Growth hormone treatment for achondroplasia","volume":"16","author":"Yorifuji","year":"2018","journal-title":"Pediat. Endocrinol. Rev. PER"},{"issue":"10252","key":"10.1016\/j.bbadis.2024.167626_bb0105","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0140-6736(20)31541-5","article-title":"Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial","volume":"vol. 396","author":"Savarirayan","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"17","key":"10.1016\/j.bbadis.2024.167626_bb0110","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s40265-021-01623-w","article-title":"Vosoritide: first approval","volume":"81","author":"Duggan","year":"2021","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167626_bb0115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167626_bb0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167626_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167626_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167626_bb0140","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bbadis.2024.167626_bb0145","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167626_bb0150","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1021\/acs.jctc.1c00810","article-title":"Efficient exploration of chemical space with docking and deep learning","volume":"17","author":"Yang","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167626_bb0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/ci100015j","article-title":"ConfGen: a conformational search method for efficient generation of bioactive conformers","volume":"50","author":"Watts","year":"2010","journal-title":"J. Chem. Inf. Model."},{"issue":"24","key":"10.1016\/j.bbadis.2024.167626_bb0160","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167626_bb0165","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/path.4739","article-title":"ATF3 deficiency in chondrocytes alleviates osteoarthritis development","volume":"239","author":"Iezaki","year":"2016","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167626_bb0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.stemcr.2018.05.020","article-title":"Translational control of Sox9 RNA by mTORC1 contributes to skeletogenesis","volume":"11","author":"Iezaki","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167626_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbrc.2014.05.108","article-title":"PI3K\/Akt is involved in brown adipogenesis mediated by growth differentiation factor-5 in association with activation of the Smad pathway","volume":"450","author":"Hinoi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bbadis.2024.167626_bb0180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbadis.2013.03.010","article-title":"Repression of adipogenesis through promotion of Wnt\/\u03b2-catenin signaling by TIS7 up-regulated in adipocytes under hypoxia","volume":"1832","author":"Nakamura","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167626_bb0185","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1002\/jcp.30883","article-title":"Conditional inactivation of the L-type amino acid transporter LAT1 in chondrocytes models idiopathic scoliosis in mice","volume":"237","author":"Iwahashi","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"5164","key":"10.1016\/j.bbadis.2024.167626_bb0190","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"vol. 264","author":"Darnell","year":"1994","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167626_bb0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","article-title":"STATs: signal transducers and activators of transcription","volume":"84","author":"Ihle","year":"1996","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167626_bb0200","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1128\/MCB.17.11.6618","article-title":"Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase","volume":"17","author":"Zhu","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"10.1016\/j.bbadis.2024.167626_bb0205","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1093\/nar\/gkad538","article-title":"CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of mediator complex proteins","volume":"51","author":"Chen","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2024.167626_bb0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167626_bb0215","first-page":"291","article-title":"Achondroplasia: development, pathogenesis, and therapy","volume":"246","author":"Ornitz","year":"2017","journal-title":"Dev. Dyn. Off. Publ. Am. Assoc. Anatomists"},{"key":"10.1016\/j.bbadis.2024.167626_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117275","article-title":"Current and emerging therapies for achondroplasia: the dawn of precision medicine","volume":"87","author":"Dardenne","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"7519","key":"10.1016\/j.bbadis.2024.167626_bb0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167626_bb0230","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2014-1914","article-title":"Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene","volume":"156","author":"Matsushita","year":"2015","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167626_bb0235","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI83926","article-title":"Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model","volume":"126","author":"Komla-Ebri","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2024.167626_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115579","article-title":"Novel therapeutic approaches for the treatment of achondroplasia","volume":"141","author":"Legeai-Mallet","year":"2020","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167626_bb0245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/14728214.2021.2005577","article-title":"Emerging therapies for achondroplasia: changing the rules of the game","volume":"26","author":"Kumble","year":"2021","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"17","key":"10.1016\/j.bbadis.2024.167626_bb0250","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1128\/MCB.01302-06","article-title":"Cdk8 is essential for preimplantation mouse development","volume":"27","author":"Westerling","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167626_bb0255","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/path.4596","article-title":"Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis","volume":"237","author":"McCleland","year":"2015","journal-title":"J. Pathol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924006203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924006203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:10:48Z","timestamp":1778551848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924006203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0925443924006203"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167626","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDK8 inhibitor KY-065 rescues skeletal abnormalities in achondroplasia model mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167626"}}